UCLA Researchers Win NIH Grant to Improve Cancer Immunotherapy Effectiveness
Dr. Cristina Puig-Saus and her research team at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 ...
Dr. Cristina Puig-Saus and her research team at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 ...
Cancer research is entering an era in which tumors are no longer viewed as isolated masses of abnormal human cells. ...
Kaposi sarcoma is not simply a tumour made of abnormal blood vessels. It is a complex tissue ecosystem in which ...
Anti-angiogenic drugs were expected to starve tumors by cutting off their blood supply. Yet many cancers eventually adapt, finding alternative ...
Breast cancer remains the most frequently diagnosed malignancy among women worldwide and is responsible for more than 650,000 deaths each ...
For years, cancer research has treated tumor cells as relatively stable enemies: cells that multiply, spread and acquire resistance through ...
Breast tumours may contain hidden “hibernation zones” where cancer cells stop dividing, evade chemotherapy and wait for an opportunity to ...
A new study is turning the microscopic “how it grows” question in colorectal cancer liver metastases into a measurable molecular ...
Tertiary lymphoid structures (TLSs)—immune-cell aggregates that form in many solid tumours—have been linked to better outcomes from immune checkpoint blockade. ...
A team investigating how tumors respond to immunotherapy reports that complement component C3 plays a decisive role—but only when it ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine